Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

Kindern. Kinder- und Jugendmedizin 2004, 2: 5–10
    Kondo, N., Fukuromi, O., Ozawa, T., Agata, H., et al.: Improvement of food-sensitive atopic dermatitis accompanied by reduced lymphocyte responses to food antigen following natural measles virus infection. Clin Exp Allergy 1993 Jan, 23 (1): 44–50
    Koskiniemi, M., Korppi, M., Mustonen, K., Rantala, H., Muttilainen, M., Herrgard, E., et al.: Epidemiology of encephalitis in children. A prospective multicentre study. Eur J Pediatr 1997, 156 (7): 541–545
    Kucukosmanoglu, E., Cetinkaya, F., Akcay, F., Pekun, F.: Frequency of allergic diseases following measles. Allergol Immunopathol 2006, 34 (4): 146–149
    Kummer, K. H.: Masernverlauf in einer Kinderarztpraxis. Der Merkurstab 1992, 3: 180–189
    Madsen, K.M., Hviid, A., Vestergaard, M., Schendel, D., et al.: A population-based study of measles, mumps, and rubella vaccination and autism. NEJM 2002, 347 (19): 1477–1482
    Marin, M., Nguyen, H. Q., Lanqidrik, J. R., Edwars, R., et al.: Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis 2006, 42 (3): 320f.
    Marshall, G. S., et al.: Diffuse retinopathy following measles, mumps, and rubella vaccination. Pediatrics 1985, 76 (6): 989ff.
    Martinon-Torres, F., Magarinos, M. M., Picon, M., Fernandez-Seara, M. J., Rodriguez-Nunez, A., Martinon-Sanchez, J. M.: Encefalopatia aguda autolimitada en relacion con el componente antisarampionoso de la vacuna triple virica (Self-limited acute encephalopathy related to measles component of viral triple vaccine). J Rev Neurol 1999, 28 (9): 881f.
    Meissner, H. C., Strebel, P. M., Orenstein, W. A.: Measles vaccines and the potential for worldwide eradication of measles. Pediatrics 2004, 114: 1065–1069
    Miller, C.: Live measles vaccine: a 21 year follow-up. BMJ (Clin Res Ed) 1987, 295 (6589): 22ff.
    Miller, C., Miller, E., Rowe, B., Bowie, C., Judd, M., Walker, D.: Surveillance of symptoms following MMR vaccine in children. The Practitioner 1989, 233: 69–73
    Miller, E., Waight, P., Farrington, C. P., et al.: Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001, 84 (3): 227–229
    Montella, M., Maso, L. D., Crispo, A., Talaminim, R., et al.: Do childhood diseases affect NHL and HL risk? A case-control study from northern and southern Italy. Leuk Res 2006, 30 (8): 917–922
    Nightingale, M.: Measles vaccine. 1999, Epoch 81/82. http:// www.whale.to/vaccines/measles_1.html (Zugriff 7. 12. 2011)
    Okazaki, N., Takeguchi, M., Sonoda, K., et al.: Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura. Vaccine 2011, 29: 4878–4880
    Olesen, A. B., Juul, S., Thestrup-Pedersen, K.: Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Derm Venereol 2003, 83 (6): 445–450
    Patja, A., Davidkin, I., Kurki, T., et al.: Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 2000, 19 (12): 1127–1134
    Patja, A., Makinen-Kiljunen, S., Davidkin, I., et al.: Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 2001, 107 (2): E27
    Paunio, M., et al.: Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol 1998, 148 (11): 1103–1110
    Paunio, M., Hedman, K., Davidkin, I., Valle, M.: Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect 2000, 124 (2): 263–271
    Plesner, A. M., Hansen, F. J., Taudorf, K., Nielsen, L. H., Larsen, C. B., Pedersen, E.: Gait disturbance interpreted as cerebellar ataxia after MMR vaccination at 15 months of age: a follow-up study. Acta Paediatr 2000, 89 (1): 58–63
    RKI (Robert-Koch-Institut): Die Anstrengungen zur Bekämpfung der Masern müssen verstärkt werden. Pressemitteilung des Robert-Koch-Instituts, 12.11.1997
    RKI (Robert-Koch-Institut): RKI -Ratgeber Infektionskrankheiten – Merkblätter für Ärzte, Masern. 2006. http:// www.hygieneinspektoren-rlp.de/infektion/ RKI _Ratgeber_Masern.pdf (Zugriff 7. 12. 2011)
    RKI (Robert-Koch-Institut): Änderung der Empfehlung zur Impfung gegen Masern. Epidem Bull 2010, 32: 315–322
    Rooth, I. B.: Supression of plasmodium falciparum infections